Classical osteoblastoma, atypical osteoblastoma, and osteosarcoma. A comparative study based on clinical, histological, and biological parameters

Clinics

Volumn 62, Issue 2, 2007, Pages 167-174

  De Oliveira, Cláudia Regina Gomes Cardim Mendes ^a   Mendonça, Berenice Bilharino ^a   De Camargo, Olavo Pires ^a   Pinto, Emilia Modolo ^a   Nascimento, Sérgio Antonio Barbosa ^a   Latorre, Maria Do Rosario D O ^a   Zerbinia, Maria Claúdia Nogueira ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Bone neoplasms; Cell proliferation; Immunohistochemistry; Osteoblastoma; p53 gene; p53 protein; Proliferating cell nuclear antigen

Indexed keywords

EID: 34248536279     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.1590/s1807-59322007000200012     Document Type: Article

References (34)

1. Lucas DR, Unni KK, Mcleod RA, O'Connor MJ, Sim FH. Osteoblastoma: clinicopathologic study of 306 cases. Hum Pathol. 1994;25:117-34.
2. Mitchell ML, Ackerman LV. Metastatic and pseudomalignant osteoblastoma. Skeletal Radiol. 1986;15:213-8.
3. Moon KS, Jung S, Lee TY, Kim SH, Kang SS. Benign osteoblastoma of the occipital bone. Case report and literature review. Neuropathology. 2006;26:141-6.
4. Morton KS, Quenville NF, Beauchamp CP. Aggressive osteoblastoma. J Bone Joint Surg. 1989;71:428-31.
5. Seki T, Fukuda H, Hanaoka H, Yatabe S, Takano M, Koide O. Malignant transformation of benign osteoblastoma. J Bone Joint Surg. 1975;57:424-6.
6. Dorfman HD, Weiss SW. Boderline osteoblastic tumors: problems in the differential diagnosis of aggressive osteoblastoma and low grade osteosarcoma. Semin Diagn Pathol. 1984;1:215-34.
7. Schajowicz F, Lemos C. Malignant osteoblastoma. J Bone Joint Surg. 1976; 58:202-11.
8. Dorfman HD, Czerniak B. Benign osteoblastic tumors. In: Bone tumors. St Louis: Mosby; 1998. p. 103-25.
9. Saghieh S, Rameh C, Birjawi G, Lakki S. Sacral osteoblastoma presenting as a L5-S1 disc herniation. Int Surg. 2005;90:289-92.
10. Mcleod RA, Dahlin DC, Beabout, JW. The spectrum of osteoblastoma. Am J Roentgenol. 1976;126:321-35.
11. Scully RE, Galdabini JJ, Mc Neely BU. Case records of the Massachusetts General Hospital. New Engl J Med. 1980;303:866-73.
12. Bertoni F, Unni KK, Mcleod RA, Dahlin DC. Osteosarcoma resembling osteoblastoma. Cancer. 1985;55:416-26.
13. O'Connor E, Stacy G. Osteoblastoma. emedicine [serial on line]. 2004, June 16. Avaiable from: http.www.emedicine.com/radio/topic494.htm
14. Della Rocca C, Huvos AG. Osteoblastoma: varied histological presentations with a benign clinical course. Am J Surg Pathol. 1996;20:841-50.
15. Dreinhofer KE, Akerman M, Willen H, Anderson C, Gustafson P. Proliferating cell nuclear antigen (PCNA) in high-grade malignant fibrous histiocytoma: prognostic value in 48 patients. Int J Cancer. 1994;59:379-82.
16. Hasegawa T, Hirose T, Seki K, Hizawa K, Ishii S, Wakabayashi J. Histological and immunohistochemical diversities, and proliferative activity and grading in osteosarcomas. Cancer Detect Prev. 1997;21:280-7.
17. Kroese MOS, Rutgers DH, Wils IS, Van Unnik JAM, Roholl PJM. The relevance of the DNA index and proliferation rate in the grading of benign and malignant soft tissue tumors. Cancer. 1990;65:1782-8.
18. Lonardo F, Ueda T, Huvos AG, Healey J, Ladanyi M. p53 and mdm2 alterations in osteosarcomas. Cancer. 1997;79:1541-47.
19. Niezabitowski A, Rys J, Roessner A, Lackowska B, Schneider-Stock R, Gruchala A, et al. Assessment of proliferative activity, DNA values and some clinicopathologic parameters in mesenchymal tumors. Gen Diagn Pathol. 1997;142:327-33.
20. Radig K, Schneider-Stoch R, Mittler V, Neumann HW, Roessner A. Genetic instability in osteoblastic tumors of the skeletal system. Pathol Res Pract. 1998;194:664-7.
21. Toguchida J, Yamaguchi T, Ritchi B, Beauchamp RL, Dayton SH, Herrera GE, et al. Mutation spectrum of p53 gene in bone and soft tissue sarcomas. Cancer Res. 1992;52:6194-9.
22. Ueda Y, Dockhorn-Dwurniczak B, Blasius S. Analysis of mutant p53 protein in osteosarcomas and other malignant and benign lesions of bone. J Cancer Res Clin Oncol. 1993;119:172-8.
23. Roessner A, Schneider-Stoch R, Radig K, Neumann W, Mittler U. Alterations of p53 gene in soft tissue and bone tumors. Gen Diagn Pathol. 1997;143:1-13.
24. Luca JW, Strong LC, Hansen MF. A germline missense mutation R 337c in exon 10 of the human P53 gene. Hum Mutat. 1998;Suppl 1: S58-61.
25. Park YB, Kim HS, Oh JH, Lee SH. The co-expression of p53 protein and p-glycoprotein is correlated with a poor prognosis in osteosarcoma. Int Orthop (SICOT). 2001;24:307-10.
26. Wright DK, Manos MM. Sample preparation from paraffin-embedded tissues. In: Innis M, editor. PCR protocols: a guide to methods and applications. San Diego: Academic Press; 1990. p153.
27. Camargo OP de, Croci AT, Oliveira CRGMC de, Baptista AM, Caiero MT. Functional and radiographic evaluation of 214 aggressive benign bone lesions treated with curettage, cauterization, and cementation: 24 years of follow-up. Clinics. 2005;60(6):439-444.
28. Guerra RB, Tostes MD, Miranda L da C, Camargo OP de, Baptista AM, Caiero MT. Comparative analysis between osteosarcoma and Ewing's sarcoma: evaluation of the time from onset of signs and symptoms until diagnosis. Clinics. 2006;61:99-106.
29. 2 and p53 in adult soft tissue sarcomas. Cancer Res. 1994; 54:794-9.
30. Moússes S, Mcauley L, Bell RS, Kandel R, Andrulis IL. Molecular and Immunohistochemical identifications of p53 alterations in bone and soft tissue sarcomas. Mod Pathol. 1996;9:1-6.
31. 2 amplification and p53 mutations found in progressive tumors. Pathol Res Pract. 1998;194:615-21.
32. Jackson DP, Lewis FA, Taylor GR, Boylsto AW, Quirke NP. Tissue extraction of DNA and RNA and analysis by the polymerase chain reaction. J Clin Pathol 1990; 43:499-504.
33. White LM, Kandel R. Osteoid-producing tumors of bone. Semin Musculoskelet Radiol. 2000;4:25-43.
34. Xarchas KC, Leviet D. Osteoblastoma of the carpal scaphoid frequency and treatment. Acta Orthop Belg. 2002;68:532-6.